Metastatic Breast Cancer
Conference Coverage
Breast cancer diagnoses worse among Hispanics during COVID-19 pandemic
A study in San Antonio suggests low insurance coverage rates may be at least partially to blame.
Conference Coverage
Structural racism tied to later-stage breast cancer diagnoses
Black patients were more likely to be diagnosed with triple-negative breast cancer than White patients.
Conference Coverage
Adjuvant chemo tied to better survival in low-risk node-positive breast cancer
The survival advantage was present in all patients under 50 years old.
Conference Coverage
Exciting advances in HR-positive breast cancer: Top five picks from SABCS
Treatments meet unmet need and address unanswered questions.
Conference Coverage
Breast conservation safe option in multisite breast cancer
After 5 years of follow-up, just 3% of women experienced a local recurrence.
Conference Coverage
CTC-guided therapy beats physician choice in metastatic breast cancer
A blood test that measures CTC could overrule physician’s choice and improve overall survival.
Conference Coverage
Women can safely interrupt endocrine therapy to pursue pregnancy
The study included more than 500 premenopausal women from 20 countries who received at least 18 months of endocrine therapy for HR+ breast cancer...
Conference Coverage
Key research on TNBC: Top five picks from SABCS
A study on the impact of platinum therapy on long-term TNBC outcomes ranks among the most popular.
News
Terminally ill cancer patients struggle to access psilocybin
“I think what we have here is a confluence of events that are driving toward the mandatory opening of a path to access psilocybin for therapeutic...
Conference Coverage
Capivasertib/fulvestrant improves progression free survival in breast cancer
The combination of the investigational AKT inhibitor capivasertib and estrogen receptor antagonist fulvestrant, doubled progression-free survival...